ARTICLE | Clinical News
Avicidin cancer therapy: Beginning a Phase I study
December 13, 1993 8:00 AM UTC
NeoRx Corp. (NERX) Product: Avicidin cancer therapy, which uses NERX's pretargeting technology to localize antibodies at tumor sites prior to administration of a radioactive isotope, which binds to th...